Ischemic nephropathy: Clinical characteristics and treatment

American Journal of Kidney Diseases

Volumn 36, Issue 5, 2000, Pages 883-893

  Alcazar, J M ^a   Rodicio, J L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

End stage renal disease (ESRD); Intravascular stents; Ischemic nephropathy; Ischemic renal disease; Percutaneous angioplasty; Renal artery stenosis; Renovascular disease; Renovascular hypertension

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE KIDNEY FAILURE; CLINICAL EXAMINATION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; HUMAN; IMAGE ANALYSIS; KIDNEY ARTERIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY ISCHEMIA; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENOVASCULAR HYPERTENSION; REVIEW; STENT;

EID: 0033736570     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2000.19077     Document Type: Article

References (94)

1. Studies on experimental hypertension. The production of persistent elevation of systolic blood pressure by means of renal ischemia
2. Clinical course of artherosclerotic renovascular disease
3. Natural history of renal artery disease
4. The natural history of atherosclerotic and fibrous renal artery disease
5. Criteria for the diagnosis of renovascular hypertension
6. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease
7. Revascularization of ischemic non-functioning kidney with restoration of renal function
8. Ischemic renal disease: An overlooked clinical entity?
9. Ischemic nepropathy
10. Atherosclerotic ischemic renal disease
11. Stenosis of renal artery: An unselected necropsy study
12. Renal artery stenosis. A clinical pathology study in normotensive and hypertensive patients
13. Prevalence of renal artery stenosis in diabetes mellitus: An autopsy study
14. Unsuspected renal artery stenosis in peripheral vascular disease
15. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere
16. The angiographic incidence of renal artery stenosis in the atherosclerotic population
17. Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension. A retrospective study
18. US Renal Data System: Executive summary
19. Renovascular disease in older patients beginning renal replacement therapy
20. Atherosclerotic renovascular disease causing renal impairment. A case for treatment
21. Influence of coexisting disease on survival on renal-replacement therapy
22. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: A 20-year clinical experience
23. Hypertension and renal dysfunction
24. Ischemic renal disease: An emerging cause of chronic renal failure and end-stage disease
25. Ischaemic renal injury
26. Prevalence and predictors of renal artery stenosis in patients with myocardial infarction
27. Clinical characteristics of atherosclerotic renovascular disease
28. Recurrent pulmonary edema in hypertension due to bilateral renal artery stenosis: Treatment by angioplasty or surgical revascularization
29. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: A distinct subgroup of patients with arteriosclerotic renal artery occlusion disease
30. Atherosclerosis renovascular disease and progressive renal failure
31. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenoses in a solitary kidney
32. Renal insufficiency and renovascular hypertension (Spanish)
33. Reversible acute renal failure following aortic thrombosis inducing bilateral renal artery occlusive disease
34. Differential renal function during angiotensin-converting enzyme inhibition in renovascular hypertension
35. Reversible renal insufficiency due to angiotensin-converting enzyme inhibitors in hypertensive nephrosclerosis
36. Acute renal failure as clinical presentation of ischemic nephropathy (Spanish)
37. Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography
38. High incidence of renal artery stenosis in patients with coronary artery disease
39. The natural history of renal artery stenosis: Who should be evaluated for ischemic nephropathy?
40. Renal artery stenosis: A common and important problem in patients with peripheral vascular disease
41. Is listening for abdominal bruits useful in the evaluation of hypertension?
42. Angiotensin-converting enzyme inhibited renography for the diagnosis of ischemic kidneys
43. The utility of duplex ultrasound scanning of the renal arteries for diagnosis of significant renal artery stenosis
44. Magnetic resonance angiography of renal artery stenosis
45. Evaluating patients with renal failure for renal artery stenosis with gadolinium-enhanced magnetic resonance angiography
46. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease
47. Metabolic alterations accompanying essential hypertension are associated with nephrosclerosis
48. Blood pressure and renal function: Therapeutic implications
49. Nephrotoxic risks of renal angiography: Contrast media-associated nephrotoxicity and atheroembolism. A critical review
50. Atheroembolic renal failure after invasive procedures
51. Redefining the incidence of clinically detectable atheroembolism
52. Cholesterol embolization. A complication of angiography
53. Renal vascular disease as a cause of hypertension
54. Percutaneous angioplasty in clinical management of renovascular hypertension: Initial and long-term results
55. Noncoronary angioplasty
56. Percutaneous left branchial catheterization using 5-French preformed (Judkins) catheters
57. Cholesterol crystal embolization in the Netherlands
58. Cholesterol crystal embolism: An important 'new diagnosis for the general physician'
59. Renovascular hypertension, anatomic, and renal function changes during drug therapy
60. Natural history of atherosclerotic renal artery stenosis associated with aortic disease
61. Long-term outcome of surgical revascularization in ischemic nephropathy: Normalization of average decline in renal function
62. Trends in surgical revascularization for renal artery disease: Ten years experience
63. Captopril renography in the diagnosis of renovascular disease
64. Contemporary surgical management of renovascular disease
65. Changing patterns in surgery for chronic renal artery occlusive diseases
66. Renal revascularization to preserve and restore renal function
67. Ischaemic nephropathy and concomitant aortic disease: A ten-year experience
68. The impact of renal revascularisation on renal dysfunction
69. Advanced renovascular hypertension and renal insufficiency: Trends in medical comorbidity and surgical approach from 1970 to 1993
70. Bilateral renal artery atherosclerosis. The results of surgical treatment
71. Hypertension and ischaemic nephropathy
72. Long-term survival after surgical revascularization for atherosclerotic renal artery disease
73. Reversal of end-stage renal failure with surgical revascularization in patients with atherosclerotic renal artery occlusion
74. Surgical management of dialysis-dependent ischaemic nephropathy
75. Renal angio-plasty in patients with azotemia and renovascular hypertension
76. Azotemia caused by renal artery stenosis: Treatment by percutaneous angioplasty
77. Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: Results in 100 patients
78. Preservation of renal function by percutaneous renal angioplasty in high-risk elderly patients: Short-term outcome
79. Percutaneous transluminal renal angioplasty in patients with renal failure
80. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study
81. Long-term results of angioplasty in 110 patients with renal artery stenosis
82. Restenosis after a first percutaneous transluminal renal angioplasty
83. Percutaneous angioplasty for atherosclerotic renal artery disease: Effect on renal function in azotemic patients
84. Renal artery angioplasty in severe atherosclerotic renovascular disease
85. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: Preliminary reports of a multicenter study
86. Treatment of ostial renal-artery stenosis with vascular endoprostheses after unsuccessful balloon angioplasty
87. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: Midterm technical and clinical results
88. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis
89. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent
90. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial
91. Stents for atherosclerotic renovascular disease
92. The value of lowering cholesterol after myocardial infarction
93. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease
94. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study